Published in Can Respir J on August 09, 2006
How can we improve guideline use? A conceptual framework of implementability. Implement Sci (2011) 2.26
A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol (2007) 1.71
Exploring mentorship as a strategy to build capacity for knowledge translation research and practice: protocol for a qualitative study. Implement Sci (2009) 1.48
Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. Can Respir J (2009) 1.47
Management of asthma in adults. CMAJ (2009) 1.43
Diagnosis of asthma in adults. CMAJ (2009) 1.41
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada. MedGenMed (2007) 1.18
Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy. BMC Pulm Med (2015) 1.17
The guideline implementability research and application network (GIRAnet): an international collaborative to support knowledge exchange: study protocol. Implement Sci (2012) 1.14
Integrating guideline development and implementation: analysis of guideline development manual instructions for generating implementation advice. Implement Sci (2012) 1.14
The air quality health index and asthma morbidity: a population-based study. Environ Health Perspect (2012) 1.06
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05
Direct health care costs associated with asthma in British Columbia. Can Respir J (2010) 1.03
Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol (2011) 1.02
WikiBuild: a new online collaboration process for multistakeholder tool development and consensus building. J Med Internet Res (2011) 1.01
Canadian Thoracic Society: Presenting a new process for clinical practice guideline production. Can Respir J (2009) 1.00
Admissions to Canadian hospitals for acute asthma: a prospective, multicentre study. Can Respir J (2010) 0.97
A children's asthma education program: Roaring Adventures of Puff (RAP), improves quality of life. Can Respir J (2010) 0.95
Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res (2012) 0.95
Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. Can Respir J (2013) 0.92
Development and pilot testing of a mobile health solution for asthma self-management: asthma action plan smartphone application pilot study. Can Respir J (2013) 0.90
"More bang for the buck": exploring optimal approaches for guideline implementation through interviews with international developers. BMC Health Serv Res (2012) 0.89
Pan-Canadian REspiratory STandards INitiative for Electronic Health Records (PRESTINE): 2011 national forum proceedings. Can Respir J (2012) 0.88
Using a knowledge translation framework to implement asthma clinical practice guidelines in primary care. Int J Qual Health Care (2012) 0.88
Asthma management made too SIMPLE. Can Fam Physician (2010) 0.88
Two for one: a self-management plan coupled with a prescription sheet for children with asthma. Can Respir J (2008) 0.87
An exploration of how guideline developer capacity and guideline implementability influence implementation and adoption: study protocol. Implement Sci (2009) 0.87
Asthma. Allergy Asthma Clin Immunol (2011) 0.87
Asthma symptoms do not predict spirometry. Can Respir J (2007) 0.86
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Identifying patients with asthma in primary care electronic medical record systems Chart analysis-based electronic algorithm validation study. Can Fam Physician (2015) 0.83
Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases. Health Serv Res (2011) 0.83
Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J (2013) 0.81
Epidemiology of bronchial asthma and asthma control assessment in Henan Province, China. Transl Respir Med (2014) 0.80
Asthma in Canada: missing the treatment targets. CMAJ (2008) 0.79
The CASE survey: patient and physician perceptions regarding asthma medication use and associated oropharyngeal symptoms. Can Respir J (2008) 0.78
The paradox of adult asthma control: "who's in control anyway?". Can Respir J (2007) 0.78
Asthma that is unresponsive to usual care. CMAJ (2009) 0.77
Enablers of Physician Prescription of a Long-Term Asthma Controller in Patients with Persistent Asthma. Can Respir J (2016) 0.77
Action plans in patients presenting to emergency departments with asthma exacerbations: Frequency of use and description of contents. Can Respir J (2014) 0.77
Asthma and chronic obstructive pulmonary disease guideline implementation: lessons learned on recruitment of primary care physicians to a knowledge translation study. Can Respir J (2013) 0.76
A randomized open-label trial on the use of budesonide/formoterol (Symbicort®) as an alternative reliever medication for mild to moderate asthmatic attacks. Int J Emerg Med (2012) 0.76
The Effectiveness of Web-Based Asthma Self-Management System, My Asthma Portal (MAP): A Pilot Randomized Controlled Trial. J Med Internet Res (2016) 0.76
Chinese expert consensus on bronchial asthma control. J Thorac Dis (2014) 0.75
Effects of a 12-month multi-faceted mentoring intervention on knowledge, quality, and usage of spirometry in primary care: a before-and-after study. BMC Pulm Med (2016) 0.75
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J (2009) 0.75
A role for pharmacists in respiratory education. Can Pharm J (Ott) (2012) 0.75
National asthma observational survey of severe asthmatics in Israel: the no-air study. Allergy Asthma Clin Immunol (2012) 0.75
Development of a web-based, work-related asthma educational tool for patients with asthma. Can Respir J (2013) 0.75
The Need for a Well-Organized, Video-Assisted Asthma Education Program at Korean Primary Care Clinics. Tuberc Respir Dis (Seoul) (2017) 0.75
The next steps. Can Respir J (2011) 0.75
Enablers and determinants of the provision of written action plans to patients with asthma: a stratified survey of Canadian physicians. NPJ Prim Care Respir Med (2017) 0.75
The link between allergic rhinitis and asthma: a role for antileukotrienes? Can Respir J (2008) 0.75
Contemporaneous International Asthma Guidelines Present Differing Recommendations: An Analysis. Can Respir J (2016) 0.75
National health guidelines in I.R of iran, an innovative approach for developing countries. Iran J Cancer Prev (2015) 0.75
Introduction from the editors. Allergy Asthma Clin Immunol (2011) 0.75
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev (2003) 5.77
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J (2000) 5.54
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol (2004) 4.17
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Assessment of practical knowledge of self-management of acute asthma. Chest (1996) 2.58
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol (2003) 2.04
Observations on asthma mortality. Ann Intern Med (1997) 1.48
Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest (1998) 1.43
Improving patient compliance with asthma therapy. Respir Med (2000) 1.35
Use of inhaled medications and urgent care services. Study of Canadian asthma patients. Can Fam Physician (1999) 1.20
Differential influences on asthma self-management knowledge and self-management behavior in acute severe asthma. Chest (1996) 1.18
Evaluation of a program aimed at increasing referrals for asthma education of patients consulting at the emergency department for acute asthma. Chest (2004) 1.16
Management of asthma among community-based primary care physicians. J Asthma (2005) 1.12
Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest (2004) 1.06
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy Asthma Immunol (2005) 0.94
The impact of a nationally coordinated pharmacy-based asthma education intervention. Can Respir J (2001) 0.92
Development and implementation of asthma guidelines. Can Respir J (1998) 0.89
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49
Management of asthma in adults. CMAJ (2009) 1.43
Diagnosis of asthma in adults. CMAJ (2009) 1.41
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Alternative therapy: cupping for asthma. Chest (2011) 1.38
Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19
Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ (2009) 1.16
What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest (2010) 1.04
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Achieving control of asthma in preschoolers. CMAJ (2009) 1.01
Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97
The coming of age of asthma guidelines. Lancet (2008) 0.96
Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial). Can Respir J (2009) 0.95
Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95
Tiotropium and chronic obstructive pulmonary disease. BMJ (2010) 0.94
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Diffuse panbronchiolitis in a Caucasian man in Canada. Can Respir J (2003) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
Approach to chronic obstructive pulmonary disease in primary care. Can Fam Physician (2008) 0.89
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology (2012) 0.88
Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res (2012) 0.87
Triple therapy for the management of COPD: a review. COPD (2011) 0.87
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest (2003) 0.86
Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma (2006) 0.85
Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients: new insights. Drugs Aging (2010) 0.85
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries. J Asthma (2013) 0.84
Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med (2009) 0.84
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Detection of COPD Exacerbations and compliance with patient-reported daily symptom diaries using a smart phone-based information system [corrected]. Chest (2013) 0.83
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med (2005) 0.83
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J (2012) 0.83
The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med (2008) 0.82
Economic issues in the use of office spirometry for lung health assessment. Can Respir J (2003) 0.82
The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract (2007) 0.82
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82
Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J (2010) 0.82
Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma (2004) 0.81
Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 0.81
The role of omalizumab in the treatment of severe allergic asthma. Can Respir J (2006) 0.81
Carbonic anhydrase inhibitors. Inhibition of the zinc and cobalt gamma-class enzyme from the archaeon Methanosarcina thermophila with anions. Bioorg Med Chem Lett (2004) 0.81
Integrating patients into meaningful real-world research. Ann Am Thorac Soc (2014) 0.81
Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol (2007) 0.80
Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med (2010) 0.79
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorg Med Chem Lett (2004) 0.79
Tiotropium and simplified detection of dynamic hyperinflation. Chest (2007) 0.79
Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J (2011) 0.78
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol (2010) 0.78
Severe bronchorrhea in a patient with bronchioloalveolar carcinoma. Chest (2012) 0.78
Plasma d-dimer for outcome assessment in patients with CAP: not a replacement for PSI. Chest (2004) 0.78
Do we know the minimal clinically important difference (MCID) for COPD exacerbations? COPD (2013) 0.77
SMART isn't. J Allergy Clin Immunol (2010) 0.76
Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. Respir Med (2009) 0.76
Leukotriene antagonists in asthma. N Engl J Med (2011) 0.75
Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J (2009) 0.75
The SMART study. Can Fam Physician (2007) 0.75
SMART therapy. CMAJ (2006) 0.75
Montelukast in childhood asthma: what is the evidence for its use? Expert Rev Respir Med (2011) 0.75
Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders. Can J Infect Dis (2003) 0.75
A step forward in COPD management: reading between the lines. Chest (2012) 0.75
The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern of cardiovascular safety? Pol Arch Med Wewn (2009) 0.75
Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respir Med (2012) 0.75
A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. J Glaucoma (2017) 0.75
Emerging concepts and therapies for chronic obstructive pulmonary disease. Pol Arch Med Wewn (2013) 0.75
New once-daily, long-acting inhaled β₂-agonist: what role will it play in the treatment of chronic obstructive pulmonary disease? Pol Arch Med Wewn (2010) 0.75
Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD (2015) 0.75
Seretide: a pharmacoeconomic analysis. J Med Econ (2008) 0.75